Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The results showed a statistically significant difference in fat loss between AOD-9604 and placebo, but the magnitude was modest
From a theoretical pharmacological standpoint, combining a peptide with putative lipolytic activity (AOD 9604) with a potent triple incretin receptor agonist (retatrutide) could potentially amplify metabolic effects but this is speculative and raises the possibility of compounding adverse effects with no safety data to guide dosing or monitoring
Lipotropic Shots (Lipo-B & Lipo-C) may NOT be suitable for individuals with: A known allergy to any of the ingredients, particularly sulfa drugs (related to Methionine)
The method you choose affects how well it works
US$ 24.53
US$ 23.09
US$ 23.93
